LICRX
Price
$15.96
Change
-$0.06 (-0.37%)
Updated
May 8 closing price
Net Assets
372.76M
VGTSX
Price
$20.74
Change
-$0.08 (-0.38%)
Updated
May 8 closing price
Net Assets
469.79B
Ad is loading...

LICRX vs VGTSX

Header iconLICRX vs VGTSX Comparison
Open Charts LICRX vs VGTSXBanner chart's image
Lord Abbett International Equity R3
Price$15.96
Change-$0.06 (-0.37%)
VolumeN/A
Net Assets372.76M
Vanguard Total Intl Stock Index I
Price$20.74
Change-$0.08 (-0.38%)
VolumeN/A
Net Assets469.79B
LICRX vs VGTSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LICRX vs. VGTSX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LICRX is a Buy and VGTSX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VGTSX has more cash in the bank: 470B vs. LICRX (373M). VGTSX pays higher dividends than LICRX: VGTSX (2.95) vs LICRX (1.07). LICRX was incepted earlier than VGTSX: LICRX (18 years) vs VGTSX (29 years). LICRX (1.22) is less costly to investors than VGTSX (0.17). LICRX is a more actively managed with annual turnover of: 89.00 vs. VGTSX (3.00). LICRX (0) and VGTSX (0) have matching initial minimum investment requirements. LICRX annual gain was more profitable for investors over the last year : 8.97 vs. VGTSX (7.98). VGTSX (48.60) and LICRX (46.67) have equivalent 5 years return.
LICRXVGTSXLICRX / VGTSX
Total Expense Ratio1.220.17718%
Annual Report Gross Expense Ratio1.220.17718%
Fund Existence18 years29 years-
Gain YTD13.2969.984133%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets373M470B0%
Annual Yield % from dividends1.072.9536%
Returns for 1 year8.977.98112%
Returns for 3 years34.7525.79135%
Returns for 5 years46.6748.6096%
Returns for 10 years30.0232.5392%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SAMVX11.16N/A
N/A
Virtus Ceredex Mid-Cap Value Equity A
VSRAX21.12N/A
N/A
Invesco Small Cap Value R
LMGYX29.76N/A
N/A
Lord Abbett Growth Opportunities I
BHCUX17.90N/A
N/A
Baron Health Care R6
FERAX11.11N/A
N/A
First Eagle Global Real Assets A